Laxido Paediatric Plain, 6.9 g sachet, powder for oral solution.
- Name:
Laxido Paediatric Plain, 6.9 g sachet, powder for oral solution.
- Company:
Galen Pharma Ireland Limited
- Active Ingredients:
Macrogol 3350, Potassium Chloride, Sodium Chloride, Sodium Hydrogen Carbonate
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 04/09/20
(Click to Download)Click on this link to Download PDF directly
Galen Pharma Ireland Limited
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 4 September 2020 PIL
Reasons for updating
- Change to section 2 - excipient warnings
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 4 September 2020
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Updated on 21 November 2019
Reasons for updating
- Change to section 8 - Marketing authorisation number(s)
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Updated on 25 April 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 25 April 2019
Reasons for updating
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Updated on 7 March 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 27 February 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 14 February 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
- Addition of manufacturer
Updated on 17 August 2018
Reasons for updating
- File format updated to PDF
Updated on 3 November 2017
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 3 November 2017 SPC
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 1 November 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 1 November 2017 PIL
Reasons for updating
- Change to section 6 - date of revision
- Change to section 6 - what the product contains
- Change to Section 1 - what the product is
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - how to take/use
- Change to section 3 - duration of treatment
- Change to section 4 - possible side effects
- Change to section 5 - how to store or dispose
Updated on 24 November 2016 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 2 September 2015 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 1 September 2015 PIL
Reasons for updating
- New PIL for new product